The Accelerating Pace Of Technological Advancement It feels like every week there’s some new gadget or software ...

In this special edition of Postmortem, Anjali Istwal examines the deteriorating law and order situation in Punjab, where ...

On this Special Report, senior journalist Aarti Jerath analyzes the growing friction between Shashi Tharoor and the Congress ...

On this Special Report, Sneha Mordani explores the rapidly evolving landscape of modern healthcare on Health360. The ...

From diagnostics to CRISPR and policy reform, explore how science and society are working together to combat the rising ...

United StatesAurum Capital has launched its Investment-Driven Medical Innovation Initiative, aiming to expand research ...

In the latest close session, CRISPR Therapeutics AG (CRSP) was down 8.7% at $55.52. The stock fell short of the S&P 500, ...

The AHA recommended whole exome or whole genome sequencing as first-line diagnostic tools for mitochondrial diseases.

New one-dose treatment edits a gene in the liver, disabling the ANGPTL3 protein and significantly lowers cholesterol.

The FDA's breakthrough therapy designation facilitates accelerated development and regulatory review for therapies showing ...

In Argentina, equine cloning in polo is no longer a rarity. It’s now a mature industry — although ethical dilemmas ...

Few companies stand better poised than Beam Therapeutics to reap the first fruits of the FDA’s promised flexibility toward cell and gene therapies. | Riding a regulatory win for its base editing ...